Found: 5
Select item for more details and to access through your institution.
Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates.
- Published in:
- Frontiers in Aging Neuroscience, 2024, p. 1, doi. 10.3389/fnagi.2024.1368291
- By:
- Publication type:
- Article
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property.
- Published in:
- Movement Disorders, 2022, v. 37, n. 10, p. 2075, doi. 10.1002/mds.29162
- By:
- Publication type:
- Article
High-fat diet–induced activation of SGK1 promotes Alzheimer's disease–associated tau pathology.
- Published in:
- Human Molecular Genetics, 2021, v. 30, n. 18, p. 1693, doi. 10.1093/hmg/ddab115
- By:
- Publication type:
- Article
Asparagine residue 368 is involved in Alzheimer's disease tau strain‐specific aggregation: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047498
- By:
- Publication type:
- Article
Clearance of seed‐dependent tau aggregation by lithium‐induced autophagy: Implications of strain‐specificity: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047342
- By:
- Publication type:
- Article